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Abstract A PCR cloning strategy using primers designed from sequences selectively conserved among a cannabinoid receptor and two orphan 
receptors, was used to isolate novel G protein-coupled receptors, rCNL3, a 1.75 kb cDNA encoding a 363 amino acid protein, was isolated from 
a rat cerebral cortex library. Sequence analysis howed that rCNL3 possesses a number of structural characteristics of G protein-coupled receptors 
and has 61% amino acid identity (from transmembrane region one through the carboxyl-terminus) with two other candidate G protein-coupled 
receptors. Therefore, these three receptors may comprise a receptor subfamily with identical or closely related endogenous ligands. Northern and 
in situ hybridization experiments demonstrated that rCNL3 mRNA is expressed in the rat brain, with a prominent distribution in striatum. 
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1. Introduction 2. Materials and Methods 
G protein-coupled receptors mediate cellular responses elic- 
ited by a wide variety of extracellular stimuli [1,2]. These stimuli 
range from photons, odorants and ions to cytokines, hormones 
and neurotransmitters. Consequently, G protein-coupled re- 
ceptors are very important for the normal functions of many 
systems, including vision, smell, immune response, endocrine 
function and neurotransmission. Abnormalities in the struc- 
tures and functions of G protein-coupled receptors are respon- 
sible for certain diseases [3,4]. Molecular cloning of novel G 
protein-coupled receptors may contribute to a better under- 
standing of the normal functions of  these receptors and the 
roles that these receptors might play in certain diseases. 
Molecular cloning studies have revealed that many G pro- 
tein-coupled receptors have common structural features, in- 
cluding seven hydrophobic putative transmembrane domains, 
six hydrophilic loops, an extracellular amino-terminus, and an 
intracellular carboxyl-terminus [2,5]. G protein-coupled recep- 
tors can be grouped into at least three superfamilies, namely the 
secretin/VIP receptor family, the metabotropic glutamate re- 
ceptor family, and the rhodopsin receptor family which con- 
tains the vast majority of the known receptors. Among these 
superfamilies, there is little sequence homology. Within each 
family, however, certain amino acid residues are well con- 
served, for example, the sequence moti f  E /DRY at the end of 
the third transmembrane domain in the rhodopsin receptor 
family. By exploiting the sequence homologies within each re- 
ceptor superfamily, approaches based on low-stringency hy- 
bridization and polymerase chain reaction (PCR) have been 
used to clone new members of G protein-coupled receptors 
[6-8]. Many of these candidate receptors later have been shown 
to have important functions [6,9,10]. In this paper, we report 
the cloning of a novel candidate G protein-coupled receptor 
that is localized predominantly to rat striatum. 
*Corresponding author. Fax: (1) (301) 402 1748. 
2.1. cDNA cloning and sequencing 
A cDNA library for rat cerebral cortex consisting of 7 × 106 clones 
was constructed in the mammalian expression vector pCD [11]. DNA 
prepared from this library or rat genomic DNA was used as a template 
for PCR. Degenerate PCR primers (CN4 and CN7) were designed 
based on conserved amino acid sequences of SKR6, edg-1 and 6-7 
(Fig. 2). SKR6 was the only cannabinoid receptor that had been cloned 
when this project was initiated [6]. edg-1 is a published orphan receptor 
[12]. 6-7 is an orphan receptor (Bonner and Brownstein, unpublished, 
GenBank Accession Number U12184) which is virtually identical to 
R334, a published orphan receptor [19], except R334 has a different 
5'-untranslated region and several apparent sequencing errors. In the 
region of the upstream PCR primer used for this study, the sequence 
of 6-7 is different from R334, probably due to a pair of frame shifts 
within R334. This pair of PCR primers was designed to isolate those 
potential receptor cDNAs that might be related to SKR6, edg-1, or 6-7. 
The sequence for the upstream primer (CN4) was 5'-CCCGGATCC 
CCI NTI NIN GGI TGG AA(C/T) TG-Y. The sequence for the down- 
stream primer (CN7) was 5"-GGGATCGAT IA(A/G) IG(C/T) 
(A/G)TA IAT IA(C/T) NGG (A/G)TT-Y. The 100/11 PCR reaction 
mixture contained 1.3/tg template DNA, 1/tM of each primer, 200/IM 
each of dATP, dTTP, dCTP and dGTP, 10 mM Tris-HCl pH 8.3, 
50 mM KCI, 2.5 mM MgCI and 2.5 units of Taq DNA polymerase 
(Perkin Elmer Cetus). PCR conditions were: 1 min at 93°C, 2 min at 
50°C, and 2 min at 72°C. After 33 cycles, the products were incubated 
for 7 min at 72°C. The PCR-amplified products of interest were puri- 
fied on a 2% NuSieve gel (FMC Bioproducts), digested with Clal and 
BamHI and then subcloned into the BamHI and AccI sites of pUCI8 
for sequencing. For making sequencing templates, DNA was amplified 
directly from individual colonies using primers pUC18rev2 (5'-ACA 
CAG GAA ACA GCT ATG ACC ATG ATT ACG AA-3") and 
pUCfor2 (5"-GTG AAA TAC CGC AGA GAT GCG-3'). The PCR- 
amplified products were then purified on Magic columns (Promega) 
and sequenced using a cycle sequencing protocol and the ABI universal 
dye sequencing primers. The sequences were analyzed on a 373A au- 
tosequencer (Applied Biosystems) and assembled with the Seqman pro- 
gram (DNASTAR). 
To isolate a full-length cDNA for the new candidate G protein- 
coupled receptor rCNL3, nick-translated probes for Southern and col- 
ony hybridization were made from the partial-length rCNL3 cDNA 
clone generated by PCR [13]. Pools and subpools of the rat cerebral 
cortex library were screened by Southern hybridization as described 
previously [14]. The full-length clone was finally isolated by colony 
hybridization. Southern and colony hybridizations were performed at 
60°C in 3 x SSPE (1 x SSPE is 0.15 M NaC1, 0.01 M NaH2PO4, 1.3 mM 
EDTA, pH 7.4), and 1 x Denhardt's solution (0.02% each of polyvinyl- 
0014-5793/94/$7.00 © 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(94)00888-4 
376 Z.H. Song et al./FEBS Letters 351 (1994) 375-379 
pyrolidone, bovine serum albumin, and Ficoll). The washing conditions 
were 60°C in 0.5 x SSPE. In order to obtain the entire cDNA sequence 
of rCNL3, subclones of this cDNA were made in pUCI8 and both 
strands of the cDNA were sequenced. 
2.2. Northern hybridization 
For northern hybridization, a 422 base pair NaeI-NsiI fragment of 
the rCNL3 cDNA corresponding to bases 1,136-1,558 was labeled with 
[3Zp]dCTP by nick-translation. A rat multiple tissue northern blot con- 
taining 2 Hg of poly(A) ÷ RNA in each lane (Clontech) was prehy- 
bridized in a solution containing 5 × SSPE, 10 × Denhardt's, 100/zg/ml 
salmon sperm DNA, 50% formamide and 2% SDS for 3 h at 42°C. The 
blot was then hybridized in the same buffer with 5 x 106 cpm/ml of 
nick-translated probe for 20 h at 42°C. The blot was washed to a final 
stringency of 0.1 x SSPE, 0.1% SDS at 60°C and exposed to X-ray film 
for up to 2 weeks. The blot was also exposed to Fuji BAS-III imaging 
plates and images were analyzed on a BAS 2000 phosphor-imaging 
system (Fuji Biomedical). 
2.3. In situ hybridization 
To construct a template for making riboprobes, a 422 bp NaeI-Nsil 
fragment of the rCNL3 cDNA (the same fragment used for Northern 
hybridization) was subcloned into the Smal and PstI sites of pGEM4Z 
vector (Promega). 35S-labeled cRNA probes were transcribed from the 
linearized template using 20/IM 35S-UTP (1,000-1,500 Ci/mmol, New 
England Nuclear), with either T7 (for anti-sense probe) or SP6 (for 
sense probe) RNA polymerase. 
Serial 12-/zm-thick frozen sections of Sprague-Dawley rat brain were 
cut on a cryostat-microtome and thaw-mounted onto gelatin-coated 
glass slides. Tissue pretreatment, hybridization and washing were per- 
formed as described previously [15]. The sections were washed to a final 
stringency of 0.1 x SSC at 65°C. Air-dried slides were exposed to Fuji 
BAS-III imaging plates for 7-10 days and images were analyzed. Sub- 
sequently, slides were coated with Ilford D5 nuclear track emulsion and 
stored at 4°C for 4 months. The slides were finally developed in D-19 
(Kodak) and counterstained with toluidine blue. 
2.4. Expression and functional analysis 
The full-length cDNAs of rCNL3 and 6-7, which were isolated from 
a rat cerebral cortex library made in the mammalian expression vector 
pCD [11], were transfected transiently into COS-7 cells using a DEAE- 
dextran method [16]. COS-7 cells were maintained inDulbecoo's Mod- 
ified Eagle's Medium containing 10% fetal calf serum. Radioligand 
binding or functional assays were carried out 72 h after transfection. 
Membrane preparation, radioligand binding, and assays of cAMP ac- 
cumulation and inositol phosphate r lease were performed as described 
previously [17]. To establish cell lines stably expressing rCNL3 or 6-7, 
CHO-K1 cells were cotransfected with rCNL3 or 6-7 cDNA and a 
plasmid conferring neomycin resistance, using a calcium phosphate 
precipitation procedure [18]. Transfected cells were selected in medium 
containing the neomycin analog G418 (400/lg/ml), cell lines expressing 
orphan receptor mRNAs were screened by RNA dot-blot analysis 
and functional assays were also performed on these stably transfected 
cells. 
3. Results 
3.1. Isolation of rCNL3 cDNA 
PCR amplification of rat genomic DNA or the DNA pre- 
pared from a rat cerebral cortex cDNA library resulted in 
products in the 420-520 base pair range. These DNA fragments 
were extracted from gel and subcloned into pUC 18 for sequenc- 
ing. In addition to SKR6, edg-1, and 6-7, two novel clones 
related to edg-1 and two novel clones related to 6-7 were iso- 
lated. Among these clones was rCNL3 which is related to 6-7. 
This partial-length rCNL3 cDNA clone was riP-labeled and 
used as a probe to screen the rat cerebral cortex library at high 
stringency. Using strategies imilar to those previously de- 
scribed [14], a cDNA clone with a 1.75 kb insert was isolated 
from this library. 
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Fig. 1. Nucleotide and deduced amino acid sequence of the candidate 
receptor rCNL3 cDNA. Nucleotide sequences are numbered beginning 
with the first residue of the initiating methionine. Putative transmem- 
brane domains are underlined. Potential N-linked glycosylation sites on 
the amino terminal are indicated by asterisks. A potential polyadenyla- 
tion signal is indicated by a dashed line. 
3.2. Structural characteristics of the rCNL3 cDNA and its 
protein product 
Fig. 1 shows the nucleotide and deduced amino acid se- 
quences of the rCNL3 cDNA clone (GenBank Accession Num- 
ber U12006). Using the first methionine codon following an 
in-frame termination codon as the translational initiation site, 
the nucleotide sequence of the rCNL3 cDNA clone contains an 
open reading frame of 1,089 base pairs, followed by a 221 base 
pair Y-untranslated region containing a polyadenylation signal 
and ending in a polyA tail. rCNL3 cDNA encodes a protein 
of 363 amino acid residues, with an estimated molecular weight 
of 38 kDa, in the absence of post-translational modifications. 
However, as illustrated in Fig. 1, the consensus equences for 
three potential asparagine-linked glycosylation sites are present 
within the amino-terminus of rCNL3. A hydropathy plot [20] 
reveals that rCNL3 has seven putative hydrophobic transmem- 
brane domains, connected by three extracellular and three in- 
tracellular loops. There is no discernible signal peptide se- 
quence at the amino terminus of rCNL3. 
Comparison of rCNL3 with several other G protein-coupled 
receptors (Fig. 2) indicated that rCNL3 has several conserved 
features of the 'E /DRY family' (rhodopsin-like family) of G 
protein-coupled receptors [2,5]. No apparent sequence homol- 
ogy was evident between rCNL3 and members of secretin/VIP 
receptor family or metabotropic glutamate receptor family. 
rCNL3 is most closely related to 6-7/R334 and GPCR21 (61% 
amino acid identity from transmembrane r gion one through 
the carboxyl-terminus), two other candidate G protein-coupled 
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Fig. 2. Alignment of the amino acid sequence of the candidate r ceptor rCNL3 with six other G protein-coupled receptors. A minimal numbers of 
gaps (-) were introduced to allow alignment. Amino acid sequences that are identical to rCNL3 are double underlined. Putative transmembrane 
domains are indicated by dashed lines. The amino acid sequences corresponding tothe PCR primers used in this study (CN4 and CN7) are indicated. 
receptors ([19,21] and Bonner and Brownstein, unpublished). 
In addition, in the same region, rCNL3 is 27% identical with 
central and peripheral cannabinoid receptors SKR6 and CX5 
[6,22], and 27% identical with two related orphan receptors 
edg I and AGR 16 [12,23] Compared to other G protein-coupled 
receptors, rCNL3, 6-7/R344, GPCR21, edg-1, AGR16 and the 
two cannabinoid receptors have several unique features. They 
all have Glu-Asn rather than Gly-Asn in transmembrane region 
1, they have no Cys residue in the second extracellular loop and 
no Pro residue in transmembrane region 5. 
3.3. Tissue distributions of rCNL3 mRNA 
Northern hybridization analysis was performed to investi- 
gate the tissue distribution and the size of rCNL3 mRNA (Fig. 
3). Under high stringency conditions, strong signal for a single 
RNA species of 2.1 kb was found in the brain after a 24 h X-ray 
film exposure. Following 2 weeks exposure on X-ray films or 
10 days exposure on Fuji imaging plates (which is about 5 times 
more sensitive than X-ray film for rip), no hybridization signal 
was detected in heart, spleen, lung, liver, skeletal muscle, kidney 
and testis. 
To examine in more detail the distribution of rCNL3 mRNA 
expression in brain, in situ hybridization histochemistry was 
conducted on rat brain coronal sections (Fig. 4). With the 
35S-labeled antisense RNA probe, hybridization signals were 
detected in the caudate-putamen, nucleus accumbens, olfactory 
tubercle and retrosplenial cortex. In contrast, with the sense 
probe, no significant signal was observed in any brain region. 
Some sections were examined at higher resolution after expo- 
sure with nuclear emulsion. Again, the labeling of cells within 
the caudate-putamen was especially prominent, with approxi- 
mately 40% of the medium-sized neurons being labeled. We 
also noted occasional labeled cells within the medial amygdala 
and stratum radiatum of the hippocampus. 
3.4. Functional analysis of rCNL3 
In our attempts to identify the ligand for the two related 
orphan receptors, rCNL3 and 6-7, cAMP accumulation (stimu- 
lation and inhibition of adenylyl cyclase) and inositol phos- 
phate release assays were performed with various potential 
ligands on rCNL3 and/or 6-7 cDNA transfected cells. In addi- 
tion, radioligand binding assays were conducted on membranes 
prepared from these cells. 
Ligands tested with cAMP accumulation assays included 
endogenous cannabinoid agonist anandamide and related 
compounds palmityl-ethanolamide, 7-1inolenylethanolamide, 
dihomo-7-1inolenylethanolamide, a renylethanolamide and 
docosahexaenyl-ethanolamide; synthetic annabinoid agonists 
Win55212-2 (a prototypic aminoalkylindole) and ( - ) - l l -hy-  
droxy-Attetrahydrocannabinol-3-dimethylheptyl(HU210);imi- 
dazo-line receptor agonist clonidine; neuropeptides ~-mela- 
nocyte stimulating hormone (ct-MSH), galanin, and calcitonin 
gene related peptide (CGRP). 
Ligands tested with inositol phosphate release assays were, 
lekotrienes B4, C4 and D4, ATP, dopamine, galanin, pancreas- 
tatin, and pancreastatin (26-51). 
Those tested with radioligand binding assays were Win 
55,212-2, glibenclamide (a sulfonyl urea), baclofen (a GABAB 
receptor agonist), nicotinamide-adenine dinucleotide (NAD), 
1,3,di-ortho-tolyl-guanidine (DTG) (a sigma receptor ligand), 
haloperidol (a sigma and dopamine receptor ligand), L-DOPA, 
(+)-butaclamol (a dopamine receptor ligand), clonidine and 
galanin. 
In our assays, none of the ligands tested were able to produce 
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any specific funtional responses on rCNL3 or 6-7 cDNA trans- 
fected cells, or bind specifically to rCNL3 or 6-7. However, 
since questions uch as whether a functional receptor is ex- 
pressed properly and coupled properly to second messenger 
systems cannot be answered without identifying the ligand for 
the receptor, at this point we can not be completely certain that 
the compounds we tested are not the ligands for these candidate 
receptors. 
4.  D iscuss ion  
In our efforts to clone novel G protein-coupled receptors, 
particularly those which might be related to cannabinoid recep- 
tors, rCNL3 cDNA was isolated from a rat cerebral cortex 
library. Like other G protein-coupled receptors, the amino acid 
sequence of rCNL3 predicts that it consists of seven hydropho- 
bic transmembrane domains and six connecting loops. In addi- 
tion, rCNL3 also has conserved amino acid residues and motifs 
typical of G protein-coupled receptors. Therefore from the 
structural characteristics of rCNL3, we conclude that it is a new 
G protein-coupled receptor. 
In this study, the tissue distributions of rCNL3 mRNA was 
first mapped by Northern hybridization analysis. Among the 
tissues that we examined, rCNL3 mRNA was detected only in 
the brain. This result indicates that rCNL3 is likely a receptor 
for a neurotransmitter or a neuromodulator. Furthermore, the 
anatomical nd cellular distributions of rCNL3 mRNA in the 
rat brain were determined by in situ hybridization histochemis- 
try. The fact that rCNL3 mRNA is found in striatum, retro- 
splenial cortex, amygdala, and hippocampus suggests that it 
may be involved in motor and learning functions. Medium- 
sized neurons in the striatum are primarily composed of two 










Fig. 3. Northern hybridization analysis of the candidate receptor 
rCNL3 mRNA expression. Each lane contained 2gg ofpoly(A) ÷ RNA 
of rat tissues. Positions of RNA molecular weight markers are indi- 
cated. A 32p-labeled fragment of rCNL3 eDNA was used for hybridiza- 
tion. The filter was washed at high stringency onditions and exposed 
to X-ray film for 14 days. 
Fig. 4. In situ hybridization analysis of the distribution of rCNL3 
mRNA in the brain. Coronal sections of rat brain were hybridized with 
either antisense (A and B) or sense (C) riboprobes of rCNL3. After 
washing under high stringency conditions, the slides were exposed to 
a Fuji imaging plate for 7 days. CP, caudate-putamen; NA, nucleus 
accumbens; OT, olfactory tubercle; Cx, cortex; RS, retrosplenial cortex. 
Bar = 5 mm. 
and the D1 receptor, whereas triatonigral neurons contain 
substance P, dynorphin, and the D2 receptor. The observation 
that approximately 40% of striatal medium-sized neurons are 
labeled by rCNL3 probe suggests that rCNL3 is expressed in 
essentially all the neurons of one of the two populations. We 
are currently engaged in further experiments o examine this 
hypothesis. 
Even though that the amino acid sequence of rCNL3 clearly 
demonstrates the structural features of G protein-coupled re- 
ceptors, the identity of the ligand of rCNL3 could not be pre- 
dicted based on the sequence similarity of rCNL3 to other G 
protein-coupled receptors. However, it is interesting to note 
that rCNL3 has high amounts of amino acid identity with two 
other orphan receptors, 6-7/R334 and GPCR21 ([19,21] and 
Bonner and Brownstein, unpublished). Therefore, these three 
orphans receptors may belong to a novel G protein-coupled 
receptor family with identical or structurally related en- 
dogenous ligands. So far, our attempts to identify the ligand for 
rCNL3 have not been successful. To understand the functions 
of rCNL3, for example what physiological roles it might play 
in striatum, further investigations are needed to identify its 
ligand and the signal transduction pathways. 
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